GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MegaPro Biomedical Co Ltd (ROCO:6827) » Definitions » Additional Paid-In Capital

MegaPro Biomedical Co (ROCO:6827) Additional Paid-In Capital : NT$124.25 Mil(As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is MegaPro Biomedical Co Additional Paid-In Capital?


MegaPro Biomedical Co's quarterly additional paid-in capital increased from Dec. 2023 (NT$46.91 Mil) to Jun. 2024 (NT$121.88 Mil) and increased from Jun. 2024 (NT$121.88 Mil) to Dec. 2024 (NT$124.25 Mil).

MegaPro Biomedical Co's annual additional paid-in capital increased from Dec. 2022 (NT$45.53 Mil) to Dec. 2023 (NT$46.91 Mil) and increased from Dec. 2023 (NT$46.91 Mil) to Dec. 2024 (NT$124.25 Mil).


MegaPro Biomedical Co Additional Paid-In Capital Historical Data

The historical data trend for MegaPro Biomedical Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MegaPro Biomedical Co Additional Paid-In Capital Chart

MegaPro Biomedical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial 0.02 220.50 45.53 46.91 124.25

MegaPro Biomedical Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.53 45.53 46.91 121.88 124.25

MegaPro Biomedical Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

MegaPro Biomedical Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of MegaPro Biomedical Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


MegaPro Biomedical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 66, Shengyi 5th Road, 10F-1, Hsinchu Science Park, Hsinchu, TWN, 31040
MegaPro Biomedical Co Ltd is a nanomedicine development company. The Company's only reportable operating segment is the Drug Application Development segment, which is engaged in the development of nano-iron oxide IOP drugs.

MegaPro Biomedical Co Headlines

No Headlines